What question did this study set out to answer?

To evaluate and compare the performance of MALDI-TOF MS systems in identifying Cryptococcus species.

April 4, 2026Open Access

Comparison of Bruker Biotyper Sirius, VITEK MS PRIME, and ASTA MicroIDSys MALDI-TOF MS Systems for Cryptococcus Species Identification Across Protein Extraction Protocols

Key Points

To evaluate and compare the performance of MALDI-TOF MS systems in identifying Cryptococcus species.
Comparative analysis of Bruker Biotyper Sirius, VITEK MS PRIME, and ASTA MicroIDSys systems
Assessment of identification accuracy across different protein extraction protocols
Evaluation of species identification success for C. neoformans and C. gattii
Sirius and PRIME showed robust performance in identifying C. neoformans
Sirius and PRIME effectively differentiated the C. gattii complex
ASTA underperformed for rarer Cryptococcus species
Single on-plate extraction proved sufficient in clinical practice
Emphasis on the need for database expansion to enhance identification accuracy

Abstract

Sirius and PRIME demonstrated robust performance for C. neoformans identification and C. gattii complex differentiation, outperforming ASTA for relatively rare species. Single on-plate extraction is sufficient in clinical practice. However, continued database expansion is essential for maximizing MALDI-TOF MS performance and accurately identifying Cryptococcus spp., thereby informing antifungal therapy and improving patient outcomes.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Park et al. (Thu,) studied this question.

synapsesocial.com/papers/69d0adc2659487ece0fa44fd https://doi.org/https://doi.org/10.3343/alm.2025.0497

Bookmark

View Full Paper